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History 
The perfusion of isolated organs 
is certainly not a new idea (Table 
1). Le Gallois, although probably 
not the first to perfuse isolated or-
gans, predicted in 1812 that life 
could be maintained in organs by 
ex vivo perfusion (Norman, Covelli 
and Sise, 1968) . 
Elaborate mechanical perfusion 
systems were developed by Ludwig 
and Schmidt in 1868 and Lindbergh 
and Carrel in the early 1900's (Car-
rel, 1912; Perry et al., 1968). 
Our current techniques have added 
significantly to knowledge in many 
fields, including physiology, trans-
plantation, immunology, toxicology, 
pathology and pharmacology. I 
will attempt to cover some of the 
TABLE 1 
History of Organ Perfusion* 
1812 
1828 
1849 
1858 
1866 
1869 
1875 
Le Gallois 
Kay 
Lobell 
Brown-Sequard 
de Cyon 
Ludwig and Schmidt 
Luchsinger 
von Fry and Gruber 
Brodie, Hamel and 
Jacobj 
1913 Carrel 
1931 Lindbergh 
1935 Carrel and Lindbergh 
* (Carrel and Lindbergh, 1938.) 
more interesting and important re-
cent developments in. perfusion and 
show its application to understand-
ing fundamental physiology. 
Systems 
Basically, there are three types 
of isolated perfusion systems. An 
isolated in vivo system has an in-
tact animal in which a specific or-
gan is isolated by cannulation. The 
importance here is that the neural 
system remains intact while the 
"isolated" organ and its responses 
are being studied. An isolated ex 
vivo system has an organ removed 
from an animal, and that animal 
( isologous) or another animal (ho-
mologous or heterologous) has its 
blood circulated through the organ, 
"If one could substitute for the heart a kind 
of injection. __ of arterial blood, either 
natural, or artificial ... , one would succeed 
easily in maintaining alive indefinitely any 
part of the body whatsoever." 
first artificial circulation to restore muscle 
kidney perfusion 
brain perfusion 
heart and liver perfusion 
perfusion apparatus 
liver perfusion 
pulsatile pump 
aeration and perfusion 
culture of organs 
coil apparatus 
thyroid perfusion lasting 18 days 
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which is usually contained in a box 
or bag. In this system, the neural 
factors are severed where as, the 
hormonal factors remain intact. Fi-
nally, a complete isolated in vitro 
perfusion system utilizes an arti-
ficial pump and various perfusate 
mixtures or anticoagulated blood. 
Neither hormonal nor neural re-
sponse mechanisms are intact in 
this system, and the circulation is 
regulated by the pump and the 
intrinsic neural mechanisms. 
Problems in Perfusion 
With these systems in mind, let 
us look at some of the problems 
in organ perfusion. In the intact in 
vivo system, problems of cell death 
are seldom encountered unless the 
drugs administered to the organ or 
the perfusion apparatus directly 
damage the cells. In vitro systems 
inevitably result in cell death no 
matter how elaborate the system or 
how nutritive the perfusate. It is im-
perative to resolve the etiology of 
cell death in ex vivo and in vitro 
systems in order to establish better 
maintenance of organs and thereby 
prolong survival for the purposes 
of study and, perhaps more im-
portantly, transplantation. 
Whether or not cell or organ 
death is due to vasospastic phenom-
ena, lack of endothelial integrity, 
or plugging by embolic fatty prod-
ucts is not yet clear. One or several 
of these phenomena may be causa-
tive, depending upon such factors 
as the mechanisms of perfusion, the 
choice of perfusate, the oxygena-
tion and the organ. It has been 
suggested (Belzer et al., 1968) that 
one cause of organ death in some 
isolated systems is emboli of lipid 
aggregates. According to Belzer, 
these emboli could cause tissue 
hypoxia with resultant cellular 
swelling, anaerobic metabolism, 
acidosis and death. The common 
denominator in cell and organ 
death is hypoxia due to inadequate 
perfusion. It has been recently dem-
onstrated (Cohen and Folkman, 
1968) that the pathogenesis in-
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volved in hypoxic cell death is in-
adequate perfusion or inadequate 
oxygenation. Hypoxemia leads to 
anaerobic glycolysis within the cell 
and produces an intracellular lactic 
acidosis. As a result, there is a 
lack of energy because of the 
anaerobic metabolism. Without en-
ergy the sodium pump mechanism 
fails, and water is imbibed into the 
cell, producing edema. The lyso-
somes swell and the resultant re-
lease of enzymes caused by acidity, 
temperature rise, or decreasing os-
motic pressure produces self-de-
struction of the cell. 
Assessing Viability 
For transplantation purposes, it 
is imperative that organ viability be 
assessed with some degree of assur-
ance prior to reimplantation. 
f 
How can one, then, detect cellular 
death early in the perfusion of iso-
lated organs so that something can 
be done? The answer to this 
question is far from being simple 
depending, as it does upon many 
factors. It is dependent upon the 
organ under study. If one is study-
ing the kidney, for example, it is 
difficult to correlate specific enzyme 
changes with cell death. Other fac-
tors, including urine output, blood 
flow and appearance, do not neces-
sarily correlate with ultimate viabil-
ity of the organ. A group of inves-
tigators (Belzer et al., 1968) have 
recently demonstrated that there 
may be some correlation between 
LDH isozymes and the prediction 
of viability of perfused kidneys. 
Rising perfusion pressure has also 
been shown to correlate with total 
renal function in isolated organs 
Heat 
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Fig. 1- The pump regulates arterial flow (A pump) and venous flow (V pump) 
separately through the livet. A bubble oxygenator is used with a heat exchanger. 
Pressures and flows (AF and VF) are continuously monitored. (Reprinted with 
permission from W. E. Gayle, Jr., G. M. Williams and D. M. Hume in Organ 
Perfusion and Preservation, Appleton-Century-Crofts, 1968, p. 807.) 
and probably indicates renal death 
(Belzer et al., 1968) . The patho-
logic mechanism is obstruction to 
the renal vasculature, and the per-
fusion pressure rises because of in-
adequate perfusion of these small 
vessels. In an organ which has an 
active enzyme system, such as the 
liver, there are more readily detect-
able enzymatic changes which cor-
relate with cell death. The major 
question here is : To what degree 
enzyme change indicates whether 
the liver will or will not survive 
and immediately support life after 
reimplantation. This is dependent 
upon the amount of anoxia it suf-
fers during extirpation, perfusion, 
preservation, and reimplantation. 
There are many parameters for 
studying acute changes of liver 
damage, the more common being 
the measurement of SGOT (serum 
glutamic oxaloacetic transaminase), 
SGPT (serum glutamic pyruvic 
transaminase), potassium and glu-
cose changes and lactate-pyruvate 
ratios. 
Regarding the applicability of 
isolated organ perfusion to trans-
plantation, one should closely ex-
amine the various ways of assaying 
viability of different organs prior 
to reimplantation. Appearance of 
the organ is often helpful in de-
tecting the presence of edema, poor 
venous return, or the presence of 
inadequate oxygenation, as, with 
these conditions, there may be 
blotchiness or poor color in gen-
eral. Excretory output can also be 
measured, although this does not 
necessarily correlate with function. 
Chemical assays, including those 
of enzyme changes in the kidney, 
liver, and heart, are important, as 
changes in perfusate pH, tempera-
ture, oxygen concentration, and 
carbon dioxide content. Pressure 
changes in the chambers of the 
heart as a measure of contractility 
may be beneficial in assaying the 
viability of the heart. Tetrazolium 
bromide dye is a rapid method for 
attempting to assay cardiac via-
bility (Maginn and Hadjimichalis, 
1968) . Jn studies by Idezuki et al. 
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( 1968) , pancreatic viability was 
determined by giving an isolated 
pancreatic graft a glucose stimula-
tion test which, if the graft was 
viable, brought about the immedi-
ate production of insulin. Even 
with minimal output of insulin 
after 48 hours of perfusion, this 
test indicated a viable graft that 
functioned on reimplantation . 
As mentioned previously, in an 
ex vitro perfusion system, the ex-
cretory functions of organs, such 
as the kidney and liver, were not 
totally reliable as adequate assays 
of viability. The kidney can put 
out large amounts of urine which is 
isosmolar with the perfusate and 
represents simply an ultrafiltrate of 
a dying kidney. Similarly, the liver 
can put out bilious-appearing ma-
terial which, if assayed, proves to 
be a poor quality of true bile and 
probably represents an ultrafiltrate 
type of material. Flow rates through 
organs depend upon several . fac-
tors: whether the perfusion is nor-
mothermic or hypothermic ; the 
method of perfusion; the type of 
pump used; whether or not the 
pressure is constant; and the 
amount of vascular resistance 
within the organ system. One elab-
orate system (Norman et al., 1967) 
provides the ability to monitor the 
intake and output via a computer-
type setup and, thereby balance 
and control the precise amount of 
flow. In our laboratories we uti-
lize a pressure-sensitive Edwards-
Boshert pump, which detects re-
sistance and, as the resistance in-
creases, automatically and propor-
tionately diminishes the flow (Fig. 
1). Diminishing flow rate provides 
us with immediate evidence of in-
travascular resistance secondary to 
vasospasm, occlusive disease, or 
other problems which raise resist-
ance and diminish inflow. We feel 
that this is a highly physiologic sys-
tem in that, essentially, it allows the 
organ to control its own flow by in-
trinsic autoregulation. 
t Edwards-Bosher Coronary Perfu-
sion Unit. J. F. Edwards Company, 
Harrisonburg, Virginia. 
Clearance studies, such as excre-
tion of dyes in the isolated kidney 
preparation or excretion of brom-
sulphalein or ammonia in the 
isolated liver preparation, are also 
utilized for detection of viability. 
These are probably somewhat more 
reliable than the simple measure-
ment of excretory rate alone, be-
cause excretion of the dye demands 
cellular function. 
Another method of assaying via-
bility is pathology, including light 
and electron microscopy. Because 
it takes time for the preparation 
of sections, these methods prevent 
obtaining conclusive evidence of 
viability immediately prior to im-
plantation. 
The sine qua non of assaying 
viability, of course, is normal func-
tion after reimplantation. This is 
the only reliable indicator of ade-
quate viability of the organ. The 
obvious problem here is that, where 
human transplantation is con-
cerned, this implies surgical manip-
ulation of the patient (recipient) 
in order to detect viability of the 
organ involved. The immediate 
need, of course, is for some quick, 
reliable, and accessible method of 
assaying viability of isolated organs 
being perfused for transplantation . 
Various aspects of such a method, 
including chemical changes, excre-
tory clearance functions and vital 
dye studies, are presently being 
pursued with the greatest interest 
at the present time. 
Mechanics of Perfusion 
Returning to more basic physiol-
ogy, let us consider some of the 
actual mechanics of perfusion of 
isolated organs . There are many 
variables in an isolated system. The 
first of these is temperature. Per-
fusion at normothermia (37 C) , 
at room temperature (25 C), or at 
considerable hypothermia ( 4-10 C), 
for the purposes of prolonged pres-
ervation, depends upon the desires 
of the investigator. Almost all phys-
iologic, pharmacologic, toxicologic, 
and immunologic studies are per-
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formed at body temperature, but, 
for the purposes of studying pres-
ervation techniques, hypothermia 
is usually utilized, since the meta-
bolic rate is markedly diminished. 
However, it produces problems, 
such as associated vasospasm and 
sludging of blood when cellular 
products are present, inactivation 
of heparin at low temperatures, 
and inactivation of certain drugs. 
Another basic consideration in 
the mechanics of perfusion is the 
presence or absence of hyperbaria. 
Belzer (Belzer, Ashby and Dun-
phy, 1967) has adequately demon-
strated that hyperbaria is not nec-
essary for the preservation of 
kidneys for a period of up to 24 
and, perhaps, even 72 hours with 
the use of hypothermia and a plasma 
solution. Other investigators (Brett-
schneider et al., 1968) have dem-
onstrated that, for their purposes, 
hyperbaria is necessary to main-
tain viability during preservation of 
human and canine livers. Recently 
it has been demonstrated that hy-
perbaria sufficiently suppresses cel-
lular swelling in the liver for a 
period of 24 hours (Huntley et al., 
1968). However, after 24 hours the 
enzymes are markedly altered, and 
the liver is not sufficiently func-
tional to support life. The perfused 
liver gains weight at a rapid rate 
after the first 24 hours, whether or 
not it is in a hyperbaric atmos-
phere. Hyperbaria may be neces-
sary for prolonged preservation of 
the pancreas and, perhaps, the 
heart and the lung. However, there 
are certain inherent disadvantages 
to hyperbaria : 1) Compression and 
decompression take several extra 
hours; 2) There is potential danger 
of an accident with the high pres-
sure system; and 3) Excess oxygen 
will damage in vitro tissue culture 
cells, although it is difficult to as-
sess its effect on whole organs. 
It has been shown that hyperbaria 
(using nitrogen or helium) will ac-
complish effects similar to those 
accomplished by hyperbaric oxy-
gen, and it is speculated that pres-
sure alone may be the important 
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factor (Lyons, Dietzman and Lil-
lehei, 1966). 
A third consideration in perfu-
sion mechanics is the type of pump 
and oxygenator utilized . As pre-
viously mentioned, we use the Ed-
wards-Bosher pump, because we 
think it is physiologically sound. 
Belzer and Folkman both utilize 
different types of pumps and ob-
tain very satisfactory results. These 
pumps are basically pulsatile. It 
has been demonstrated by work in 
our own laboratory (Robertshaw 
and Gayle, unpublished data) and 
by others (Tait and Eisenman, 
1966) that pulsatile perfusion al-
lows lymphatics to empty during 
the diastolic phase and, therefore, 
diminishes edema formed in the 
parenchyma and around the capsule 
of the organs. The type of oxygena-
tor is also important. It has recently 
been demonstrated that disc oxy-
genators, which have a large sur-
face contact with the actual perfu-
sate, have increased screen filtra-
tion pressure (Ashmore, Svitek 
and Ambrose, 1968) and as pre-
viously mentioned (Belzer et al., 
1968), may cause problems with 
embolization of fatty materials. 
Membrane oxygenators have been 
utilized for bypass over periods of 
12 to 24 hours and have a very 
minimal increase in screen filtra-
tion pressure. We have recently 
switched to a membrane oxygenator 
for our preservation system but 
have, however, been able to suc-
cessfully preserve some kidneys for 
24 hours with a disc oxygenator. 
TABLE 2 
Perfusates for Preservation 
A fourth area of importance in 
perfusion is the choice of perf usate. 
Again, there is much controversy 
as to the exact type of perfusate to 
use. This is dependent upon the 
type of study desired by the indi-
vidual investigator. If the system 
is to be as physiologic as possible, 
a whole blood or dilute whole blood 
solution is utilized. Problems in-
volved, however, are sludging and 
outflow block-especially in the 
liver-if a whole blood solution 
is utilized. Regardless of the per-
fusate used, perfusion of the lungs, 
without ventilation, is problemat-
ical for maintenance of viability 
(Stevens et al., 1968). In preser-
vation (Table 2), dilute whole 
blood solutions have worked satis-
factorily with lung and liver. With 
kidney preservation, the use of a 
plasma solution has been shown by 
Belzer to be the most satisfactory 
(Belzer et al., 1967) . The use of 
crystalloid solutions has been shown 
by some investigators to be nearly 
as effective as that of plasma. How-
ever, one does run into the problem 
of edema after occurring long 
preservation. Depending upon the 
study, many additives have been 
utilized in perfusates, including 
magnesium, steroids, antibotics, 
adenosine (Stewart and Wilbrandt, 
1968) , chlorpromazine, buffering 
agents, glucose and insulin. 
The question of inclusion of cells 
in the perfusate has been a very 
controversial one. Up until recently 
it was thought that platelets might 
be harmful; however, it appears that 
Kidney- homologous undiluted ACD plasma, room air, pulsatile perfusion, 
moderate hypothermia 
Liver- dilute heparinized whole blood, hyperbaric oxygen, hypothermia 
Lung- ventilation, ? perfusion (dextran-ACD-blood), ? hyperbaria (2A) 
Pancreas- non-perfusion relatively successful to 22 hours 
Thymus- Eagle's MEM, fetal calf serum 
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Fig. 2- Isoproterenol added to an isolated perfused liver with a falling venous flow produced immediate increase in flow. 
Folkman has renewed the desire to 
have platelets present to insure phys· 
iologic preservation of the endothe-
lium (Gimbrone et al., 1969). He 
and his colleagues have demon-
strated that the platelet, which is 
thought by some to contribute to 
problems in isolated organ perfu-
sion, may be an important factor 
in maintaining the integrity of the 
vascular endothelium. They have 
recently demonstrated this by per-
fusing dog thyroid glands with 
platelet-rich plasma and comparing 
them to thyroids perfused simul-
taneously with platelet-poor plasma 
under identical conditions. The 
endothelium seems to be main-
tained with adequate function after 
re-anastomosis in organs perfused 
with platelet-rich plasma for 24 
hours. Platelet-poor perfused thy-
roids, however, after a period of 
three to four hours, swell and have 
petechial and purpuric hemorrhages 
in their subcapsular area on reim-
plantation. This is perhaps the new-
est and most exciting concept in 
organ perfusion and preservation 
and goes against the theory of many 
workers in the past (Humphries, 
1967). 
One final perfusate which has 
been used for maintenance of 
perfusion in isolated organs (Paton 
et al., 1968) and in the total rat 
model (Geyer, Monroe and Taylor, 
1968) is the fluorocarbon perfusate 
(Pluronic F-68) . Geyer et al. have 
described a highly intriguing appli-
cation in which rats were com-
pletely exchanged with a fluorocar-
bon-serum emulsion without cells, 
maintained at 100% oxygen at-
mosphere, and kept alive for six to 
eight hours. If washed erythrocytes 
were added to fluorocarbon emul-
sion, the animal survived indefi-
nitely after being perfused for up to 
140 minutes. 
MCV Data 
At this point I would like to re-
late some of the work recently 
done in our laboratory to the as-
pects of organ perfusion and 
transplantation. Doctor William 
Harlan (O'Brien, H arlan and White, 
unpublished data) has recently 
shown that palmitic acid, which is 
probably the major source of en-
ergy for the renal cortex, is mark-
edly diminished in canine renal al-
lografts as compared to isografts 
and normals. It is hoped that we 
can apply this work and its im-
plications to the study of rejection. 
Other studies relevant to trans-
plantation are being performed 
by one of our medical students, Mr. 
Harold Levinson, who is using an 
isolated rat perfusion system mod-
eled after that of Doctor Judah 
Folkman to study in :vitro aspects 
of rejection. Utilizing PA and Lewis 
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rat strains, lymphocytes can be ob-
tained from the thoracic duct of 
one rat strain. Either a culture 
medium which is isologous to one 
rat strain or a medium, such as 
Medium 199, which is indifferent 
to both strains, is used to suspend 
the cells. Thoracic duct lym-
phocytes, tagged with chromium 
153, are utilized to perfuse syn-
geneic and allogeneic rat strains. 
Counts of the venous effluent as 
well as counts of the total kidney 
are monitored after a standard per-
fusion time. These data appear to 
demonstrate that the allogeneic 
kidney took up more sensitized lym-
phocytes than did the syngeneic 
kidney. Preliminary data on the 
venous effluents, however, have not 
proved consistent in their results. 
Utilizing tagged red cells to reveal 
whether the kidneys were being 
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Fig. 4-Vasospasm with arterial and venous flow diminution is produced with epinephrine. (Reprinted with permission from 
W. E. Gayle, Jr., G. M. Williams and D. M. Hume in Organ Perfusion and Preservation, Appleton-Century-Crofts, 1968, p. 810.) 
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Fig. 5-Norepinephrine produced similar results. 
adequately perfused, Levinson dem-
onstrated that the kidneys are not 
always being perfused equally in 
the cortical and medullary areas. 
Doctor Gilbert Robertshaw has 
published an excellent report on the 
presence of serum antibody which 
is not cell-bound (Robertshaw et 
al., 1967). One of a set of unre-
lated mongrel dogs was subjected to 
a first-set transplant that used a 
kidney which was allowed to reject 
and was then removed. After a 
short rest period, a second-set graft 
was performed utilizing either skin 
or spleen. Skin grafts were subse-
quently performed until a "white-
graft" reaction was obtained, im-
plying hyperacute rejection. The 
kidneys of the original donor were 
placed in a perfusion circuit, and 
the serum of the hypersensitized 
recipient dog was added to the per-
fusion system after a baseline was 
obtained. It was immediately dem-
onstrated that the donor kidney 
swelled, and the urine output di-
minished rapidly. A recipient kid-
ney was used as a control. Upon 
analyzing these data, Robertshaw 
found that there was a decrease in 
renal arterial flow, oxygen uptake 
across the kidney, urine output and 
urine osmolality in the donor kid-
ney. Pathologic examination re-
vealed proteinuria and increased 
edema. 
In a more recent study (Robert-
shaw et al. , unpublished data) the 
donor kidney, after being perfused, 
was replaced in the donor animal 
and allowed to perfuse for 30 min-
utes to 2 hours. Urine output re-
mained low. On pathologic exami-
nation, polymorphonuclear leuko-
cytes were shown to adhere to the 
endothelial lining of the kidneys, 
demonstrating continuance of the 
hyperacute rejection phenomenon. 
Work done with isolated liver per-
fusions in our laboratory has dem-
onstrated that there are probably 
beta-adrenergic receptors within 
the vasculature of the liver which 
are affected by isoproterenol (Figs. 
2, 3) and tend to cause vasodilata-
tion of the postsinusoidal sphincter 
mechanism (Gayle, Williams and 
Hume, 1968). This causes relaxa-
tion and allows increased flow, 
especially if the system has been 
previously subjected to vasospastic-
ity with either norepinephrine or 
epinephrine, both of which produce 
marked vasoconstriction and dimi-
nution of flow through the liver 
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(Figs. 4, 5). With the adminis-
tration of isoproterenol, increased 
flow is more marked in the venous 
phase than in the arterial phase 
(Figs. 6, 7). Lymphatic output, as 
measured by direct cannulation of 
perihilar lymphatics, is increased 
with the administration of vasocon-
strictive agents. With the relaxation 
of the sphincter accomplished by 
isoproterenol, the lymphatic output 
diminishes. It is our feeling that if 
post-hepatic transplantation support 
to the cardiovascular system were 
needed, isoproterenol would prob-
ably be the drug to choose, since 
vasopressor agents, such as norepi-
nephrine or epinephrine, would 
harm the liver by causing vaso-
spasm. However, not enough work 
has been done with human livers to 
definitely corroborate this in the 
human system. We are also, at pres-
ent, working on effects of certain 
anesthetic agents on hepatic flows 
and pathologic changes. 
Conclusions 
Isolated organ perfusion provides 
us with an excellent tool for in-
vestigating the physiology and the 
function of a variety of individual 
organs. It enables us to explore 
these organs, their pbarmacologic 
reactions, their ability to withstand 
various stresses, their pathology 
after stress and their suitability for 
preservation and transplantation. 
Isolated perfusion has allowed us 
to better understand hemodynam-
ics, effects of various perfusates, 
and toxicity of drugs on individual 
organs. We have recently been en-
lightened about the vital role of 
platelets and endothelial integrity. 
We now have a model for assessing 
individual hormonal systems and 
qualitative and quantitative endo-
crine and exocrine functions. Organ 
perfusion has provided us with 
a method for preservation and a 
means for studying organ viability 
prior to transplantation. We now 
have an invaluable isolated system 
in which we can study certain 
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dog livers after injection. Drug 2 is epinephrine and Drug 3 is norepinephrine. 
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p. 811.) 
aspects of immunology, including 
the rejection mechanism, sensitiza-
tion, and the evaluation of serum 
and cell-bound phenomena. Our 
immediate goals include detection 
of cell or organ death prior to re-
implantation by some rapid and 
accurate method and prolongation 
of preservation time for in vitro or-
gan systems. 
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